Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9.48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]

Related Keywords

Diana Hausman , Stifel Nicolaus , Zentalis Pharmaceuticals Inc , News Ratings For Zentalis Pharmaceuticals Daily , Zentalis Pharmaceuticals Company Profile , Nasdaq , Decheng Capital , Vanguard Group Inc , Pricet Rowe Associates Inc , Zentalis Pharmaceuticals Stock Down , Institutional Trading Of Zentalis Pharmaceuticals , Hermes Inc , Zentalis Pharmaceuticals , Eventide Asset Management , Get Free Report , Pharmaceuticals Stock Down , Asset Management , Federated Hermes , Zentalis Pharmaceuticals Daily ,